{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Atopy&page=19", "query": { "condition": "Atopy", "page": 19 }, "page_size": 10 }, "pagination": { "page": 19, "page_size": 10, "total_count": 711, "total_pages": 72, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Atopy&page=20&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Atopy&page=18&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-27T20:03:39.802Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03985943", "title": "Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Moderate-to-Severe Atopic Dermatitis" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Nemolizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Galderma R&D", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 941, "start_date": "2019-06-27", "completion_date": "2022-08-11", "has_results": true, "last_update_posted_date": "2024-08-14", "last_synced_at": "2026-10-27T20:03:39.802Z", "location_count": 57, "location_summary": "North Little Rock, Arkansas • Cerritos, California • Fountain Valley, California + 48 more", "locations": [ { "city": "North Little Rock", "state": "Arkansas" }, { "city": "Cerritos", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Lomita", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03985943" }, { "nct_id": "NCT04990440", "title": "A Study of Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dermatitis, Atopic" ], "interventions": [ { "name": "Bermekimab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 6, "start_date": "2021-09-02", "completion_date": "2022-03-09", "has_results": true, "last_update_posted_date": "2023-05-24", "last_synced_at": "2026-10-27T20:03:39.802Z", "location_count": 6, "location_summary": "Indianapolis, Indiana • Chesterfield, Michigan • Tulsa, Oklahoma + 2 more", "locations": [ { "city": "Indianapolis", "state": "Indiana" }, { "city": "Chesterfield", "state": "Michigan" }, { "city": "Tulsa", "state": "Oklahoma" }, { "city": "Dallas", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04990440" }, { "nct_id": "NCT05718921", "title": "A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Atopic Dermatitis", "Psoriasis" ], "interventions": [ { "name": "YR001 Dose A on low body surface area", "type": "DRUG" }, { "name": "YR001 Dose A on middle body surface area", "type": "DRUG" }, { "name": "YR001 Dose A on high body surface area", "type": "DRUG" }, { "name": "YR001 Dose B on low body surface area", "type": "DRUG" }, { "name": "YR001 Dose B on middle body surface area", "type": "DRUG" }, { "name": "YR001 Dose B on high body surface area", "type": "DRUG" }, { "name": "Placebo on low body surface area", "type": "DRUG" }, { "name": "Placebo on middle body surface area", "type": "DRUG" }, { "name": "Placebo on high body surface area", "type": "DRUG" }, { "name": "YR001 Dose A on high body surface area twice daily", "type": "DRUG" }, { "name": "YR001 Dose B on high body surface area twice daily", "type": "DRUG" }, { "name": "Placebo on high body surface area twice daily", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hangzhou Yirui Pharmaceutical Technology Co., Ltd", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 54, "start_date": "2023-04-08", "completion_date": "2023-12-14", "has_results": false, "last_update_posted_date": "2024-01-24", "last_synced_at": "2026-10-27T20:03:39.802Z", "location_count": 1, "location_summary": "Encinitas, California", "locations": [ { "city": "Encinitas", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05718921" }, { "nct_id": "NCT01232985", "title": "Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis", "Pruritus" ], "interventions": [ { "name": "RD047-26", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Oculus Innovative Sciences, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 17, "start_date": "2010-10", "completion_date": "2010-12", "has_results": false, "last_update_posted_date": "2012-05-30", "last_synced_at": "2026-10-27T20:03:39.802Z", "location_count": 1, "location_summary": "High Point, North Carolina", "locations": [ { "city": "High Point", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01232985" }, { "nct_id": "NCT06015308", "title": "A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dermatitis Atopic" ], "interventions": [ { "name": "Amlitelimab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Tdap vaccine", "type": "BIOLOGICAL" }, { "name": "PPS vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 224, "start_date": "2023-10-06", "completion_date": "2026-01-16", "has_results": false, "last_update_posted_date": "2026-08-10", "last_synced_at": "2026-10-27T20:03:39.802Z", "location_count": 47, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Anaheim, California + 40 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Fremont", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06015308" }, { "nct_id": "NCT05735483", "title": "A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atopic Dermatitis", "Eczema" ], "interventions": [ { "name": "Lebrikizumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "18 Years", "sex": "ALL", "summary": "6 Months to 18 Years" }, "enrollment_count": 338, "start_date": "2023-03-09", "completion_date": "2029-04", "has_results": false, "last_update_posted_date": "2026-10-26", "last_synced_at": "2026-10-27T20:03:39.802Z", "location_count": 21, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • North Little Rock, Arkansas + 18 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "North Little Rock", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05735483" }, { "nct_id": "NCT05439941", "title": "A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 Trials", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "EDP1815", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Evelo Biosciences, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "76 Years", "sex": "ALL", "summary": "18 Years to 76 Years" }, "enrollment_count": 287, "start_date": "2022-06-06", "completion_date": "2023-06-07", "has_results": true, "last_update_posted_date": "2023-09-07", "last_synced_at": "2026-10-27T20:03:39.802Z", "location_count": 24, "location_summary": "Birmingham, Alabama • Fountain Valley, California • Fremont, California + 19 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Fremont", "state": "California" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05439941" }, { "nct_id": "NCT04740892", "title": "A Study of a Moisturizing Cream and Baby Wash in the Management of Mild to Moderate Atopic Dermatitis in Infants, Toddlers and Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dermatitis, Atopic" ], "interventions": [ { "name": "Wash IP", "type": "OTHER" }, { "name": "Cream IP", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Johnson & Johnson Consumer Inc. (J&JCI)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "72 Months", "sex": "ALL", "summary": "3 Months to 72 Months" }, "enrollment_count": 31, "start_date": "2021-01-21", "completion_date": "2023-02-06", "has_results": false, "last_update_posted_date": "2024-02-06", "last_synced_at": "2026-10-27T20:03:39.802Z", "location_count": 2, "location_summary": "High Point, North Carolina • Lynchburg, Virginia", "locations": [ { "city": "High Point", "state": "North Carolina" }, { "city": "Lynchburg", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04740892" }, { "nct_id": "NCT06899204", "title": "Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Atopic Dermatitis", "Atopic Dermatitis, Unspecified", "Dermatitis, Atopic" ], "interventions": [ { "name": "Abrocitinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 150, "start_date": "2026-04-24", "completion_date": "2027-02-15", "has_results": false, "last_update_posted_date": "2026-08-17", "last_synced_at": "2026-10-27T20:03:39.802Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06899204" }, { "nct_id": "NCT00124709", "title": "Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Pimecrolimus", "type": "DRUG" }, { "name": "Corticosteroid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "18 Months", "sex": "ALL", "summary": "3 Months to 18 Months" }, "enrollment_count": 1091, "start_date": "2003-10", "completion_date": "2008-11", "has_results": true, "last_update_posted_date": "2011-03-23", "last_synced_at": "2026-10-27T20:03:39.802Z", "location_count": 36, "location_summary": "Birmingham, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 33 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00124709" } ] }